NEW DELHI: In what could be good news for patients, Indian Patent Office (IPO) has rejected MNC AbbVie’s patent application for its blockbuster cancer drug Venetoclax citing lack of inventive step.
The EU’s long-delayed Entry/Exit System (EES) for non-EU nationals began being phased in last October. The gradual scale-up of the biometric border technology has already experienced teething problems ...
Prompt injections have become one of the biggest emerging threats to the modern home as AI adoption grows. It's a new era of malware -- and one that requires new defenses. Tyler Lacoma Editor / Home ...
Correspondence to Dr Margo Mountjoy, Department of Family Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON N2G 1C5, Canada; mmsportdoc{at}mcmaster.ca In 2014, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results